Therapeutic Angiogenesis With Intramuscular NV1FGF in Patients With Critical Limb Ischemia - TALISMAN

Description:

The goal of the trial was to evaluate treatment with intramuscular NV1FGF, a pCOR plasmid for expression of fibroblast growth factor-1 (FGF-1) compared with placebo among patients with critical limb ischemia (CLI).